Shanghai Baoju
Retatrutide
Finnrick tested 6 samples of Retatrutide (GLP-1, GIP, and GCGR agonist) from Shanghai Baoju between 3 Oct 2025 and 26 Jan 2026. Test scores average below 4 or some scores below 3, and at least 6 tests, warrant a confident Finnrick Rating of E (Bad).
Finnrick Rating™
Shanghai Baoju
Retatrutide
Tested 6 Samples
Last test 26 Jan 2026
Take Action
Researcher
Request Full Data Access to the Finnrick database of peptide tests.
Free peptide testing
Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.
Other Retatrutide tests from top-rated vendors:
All Retatrutide tests from Shanghai Baoju
Samples are tested in commercial labs
Tests Count
6
Scores
AVGMINMAX
Last
26 Jan 2026
First
3 Oct 2025
| Quantity | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Certificate | Test Score | Label | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 26 Jan 2026 | View | 10mg | ⚠️ Sample does not contain Retatrutide | 11/2025 | White Label / Silver Crimp / Clear Blue Cap | Lab E | Public | |||
| 16 Dec 2025 | View | 10mg | ⚠️ Sample does not contain Retatrutide | 11/2025 L | White Label / Silver Crimp / Clear Blue Cap | Lab G | Public | |||
| 16 Dec 2025 | View | 20mg | 19.6mg | -2.0% | 99.70% | 11/2025 L | White Label / Silver Crimp / Violet Cap | Lab G | Public | |
| 25 Nov 2025 | View | 20mg | 22.5mg | +12.5% | 99.95% | (no batch ID) | No Label / Silver Crimp / Clear Pink Cap | Lab E | Public | |
| 14 Nov 2025 | View | 5mg | 5.1mg | +2.0% | 99.80% | (no batch ID) | No Label / Silver Crimp / Clear Pink Cap | Lab G | Public | |
| 3 Oct 2025 | View | 5mg | 4.64mg | -7.2% | 99.93% | (no batch ID) | White Label / Silver Crimp / Violet Cap | Lab E | Public | |